In recent trading activity, shares of Alignment Healthcare Inc (Symbol: ALHC) have surged above the average analyst 12-month target price of $13.27, currently trading at $13.50 per share. When a stock hits an analyst’s target price, the typical responses include either a downgrade due to valuation concerns or an upward adjustment of the target price. The decision can be influenced by positive developments in the company’s fundamentals that might justify a higher target.
Analyst Target Price Insights
There are 11 different analyst targets that contribute to the average price for Alignment Healthcare Inc. While the average provides a general sense, it encompasses a wide range of opinions—from a low target of $8.00 to a high target of $17.00. The calculated standard deviation among these recommendations is $2.359, indicating variations in analyst expectations.
Investor Considerations Following Price Movement
The rationale behind monitoring the average ALHC price target stems from the collective insights of various analysts, rather than relying on a single viewpoint. With ALHC trading above the average target price of $13.27, current investors now have an opportunity to reassess the company’s potential: Did the stock just reach a temporary milestone, or is it on the path towards a significantly higher valuation? The following table summarizes the current ratings from analysts covering Alignment Healthcare Inc:
| Recent ALHC Analyst Ratings Breakdown | ||||
|---|---|---|---|---|
| » | Current | 1 Month Ago | 2 Month Ago | 3 Month Ago |
| Strong buy ratings: | 9 | 9 | 8 | 8 |
| Buy ratings: | 0 | 0 | 0 | 0 |
| Hold ratings: | 3 | 3 | 4 | 4 |
| Sell ratings: | 0 | 0 | 0 | 0 |
| Strong sell ratings: | 1 | 1 | 1 | 1 |
| Average rating: | 1.77 | 1.77 | 1.92 | 1.92 |
The average rating, shown in the last row, is based on a scale where 1 signifies a Strong Buy and 5 indicates a Strong Sell. Data for this article has been sourced from Zacks Investment Research via Quandl.com. For the latest Zacks research report on ALHC, it is available for free.
10 ETFs With Most Upside To Analyst Targets »
Also see:
• Institutional Holders of EIV
• XRT YTD Return
• Funds Holding SJCP
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
